Daniel Alpern

Daniel Alpern is the current CTO and co-founder of Alithea Genomics. Daniel was previously a postdoctoral fellow at EPFL from February 2009 to October 2014, and a research associate at the Russian Cancer Research Center from May 2004 to November 2008. Daniel has a PhD in Biology from the University of Illinois at Urbana-Champaign.

Daniel Alpern reports to Riccardo Dainese, CEO & Co-Founder. Some of their coworkers include Daria Gudkova - Project Manager, Diana Solis - Bioinformatician, and Andreia Lopes - R&D Technician.